Advanced Proteome Therapeutics Stock

• GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine

GE HealthCare Technologies (NASDAQ:GEHC) executives said the company remains confident in its long-term growth prospects despite a

Calian Group (TSE:CGY) reported record second-quarter revenue and sharply higher adjusted EBITDA, with management pointing to accelerating demand in defense and space markets, improved execution

NeoVolta (NASDAQ:NEOV) reported third-quarter fiscal 2026 revenue of approximately $2 million, roughly in line with the year-earlier period, while management emphasized progress on its transition

• 2 Lesser-Known Photonics Firms May Play an Outsized Role in AI

Nova (NASDAQ:NVMI) reported record first-quarter 2026 revenue and profitability, with management citing strong demand from advanced

• Want Diversified Upside in Biotechnology? Check out LABU

Arrowhead Pharmaceuticals (NASDAQ:ARWR) is moving into a more commercial phase while continuing to expand its RNA interference pipeline

• Before the Moon Base Gets Built, These 4 Companies Win

Aeluma (NASDAQ:ALMU) executives said the company is seeing increased customer interest in its photonics technology as artificial intelligence

ClearPoint Neuro (NASDAQ:CLPT) reported record first-quarter 2026 revenue and reaffirmed its full-year outlook, as management highlighted growth in its legacy neurosurgical device business and

Lumexa Imaging (NASDAQ:LMRI) reported first-quarter results that management said were in line with expectations, as growth in advanced imaging modalities helped offset seasonal volume pressure and

Novanta (NASDAQ:NOVT) reported stronger-than-expected first-quarter 2026 results, with management citing broad-based bookings growth, accelerating demand in automation and medical markets, and